| Health / Medical Topics |
Synchrovax SEM Plasmid DNA Vaccine
A bivalent DNA vaccine encoding epitopes for both Melan-A (MART-1) and tyrosinase with potential antineoplastic activity. Synchrovax SEM plasmid DNA vaccine contains a plasmid pSEM that encodes 4 epitopes: Melan-A (26-35), Melan-A (31-96), tyrosinase (1-9), and tyrosinase (369-377). Both Melan-A and tyrosinase are tumor antigens associated with melanoma. Vaccination with this plasmid DNA vaccine may induce both humoral and cytotoxic lymphocyte (CTL) responses against cells expressing either or both of these antigens, resulting in decreased tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A device that accelerates particles in a circular orbit at a fixed radius. The acceleration is performed in an increasing magnetic field…
A recombinant plasmid DNA vaccine encoding epitopes of tyrosinase with potential antineoplastic activity. Synchrotope TA2M vaccine contains a plasmid encoding 2 epitopes,…
A bone osteosarcoma affecting multiple skeletal sites, with multifocal lesions discovered within 6 months of the appearance of the initial tumor. …
Carcinoma that is detected in one breast within two months from the diagnosis of carcinoma in the other breast.
Occurring at the same time or rate.
A mechanical device on a transmission designed to make the gears spin at the same speed.
